Diamond was the only director who had real skin in ANP. As nice as the future prospects look for ANP, the elephant in the room is the need for capital to fund the whole trial. With a new CEO coming in with also no skin in the game, if I were him, I'd rip the bandaid off and raise the funds needed first up and participate in any raise. Until the capital question is answered I cant see this going too far north.
ANP Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
